FDA Inspection 1086860 — Jiri Vyhnal, MD
The FDA completed an inspection of Jiri Vyhnal, MD on April 11, 2019 in Kyjov. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 11, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kyjov (Czech Republic)
Additional Details
Clinical Investigator (CI)